Related Experiment Video

Updated: Sep 24, 2025

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

13.3K

TGF-β1-induced RAP2 regulates invasion in pancreatic cancer

Kaizhou Jin1,2,3,4, Chen Liu1,2,3,4, He Cheng1,2,3,4

  • 1Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.

Acta Biochimica Et Biophysica Sinica
|May 10, 2022
PubMed

Insights

Ras-related protein-2a (RAP2) is upregulated in pancreatic cancer, correlating with poor survival. Silencing RAP2 inhibits cancer cell invasion, identifying it as a potential therapeutic target for this lethal disease.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Pancreatic cancer is a highly lethal malignancy characterized by aggressive invasion and metastasis.
  • There is a critical need for novel therapeutic targets to combat pancreatic tumors with high invasive potential.
  • Ras-related protein-2a (RAP2), a GTP-binding protein, is implicated in various cancers but its role in pancreatic cancer remains underexplored.

Purpose of the Study:

  • To investigate the correlation between RAP2 expression and overall survival in pancreatic cancer patients.
  • To elucidate the mechanistic role of RAP2 in pancreatic cancer invasion and its regulation.
  • To identify RAP2 as a potential predictive marker and therapeutic target for pancreatic cancer.

Main Methods:

  • Analysis of RAP2 expression levels in relation to patient survival data.
  • In vitro studies involving the silencing of RAP2 to assess its impact on pancreatic cancer cell invasion.
  • Investigation of the regulatory pathway of RAP2 expression, including the role of transforming growth factor-β1 (TGF-β1) and c-Myc.

Main Results:

  • Higher RAP2 expression was significantly associated with unfavorable prognoses in pancreatic cancer patients.
  • Silencing RAP2 expression effectively inhibited the invasive capacity of pancreatic cancer cells.
  • Transforming growth factor-β1 (TGF-β1) was identified as a regulator of RAP2 expression, mediated by the transcription factor c-Myc.

Conclusions:

  • RAP2 expression serves as a predictive marker for poor survival in pancreatic cancer.
  • RAP2 plays a crucial role in promoting pancreatic cancer cell invasion.
  • Targeting RAP2 presents a promising therapeutic strategy for pancreatic cancer treatment.
Keywords:
RAP2TGF-β1c-Mycinvasionpancreatic cancer

More Related Videos

Spheroid Assay to Measure TGF-β-induced Invasion09:18

Spheroid Assay to Measure TGF-β-induced Invasion

Published on: November 16, 2011

22.0K
In Vitro Modeling of Cancerous Neural Invasion: The Dorsal Root Ganglion Model08:23

In Vitro Modeling of Cancerous Neural Invasion: The Dorsal Root Ganglion Model

Published on: April 12, 2016

9.4K

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.8K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
2.8K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
4.3K